FSNUY Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 июнь 2024 @ 22:13):
Our systems believe the stock currently is undervalued by 0.81% compare to its pairs and should correct upwards.

Stats
Объем за сегодня	25 709
Средний объем	64 070
Рыночная капитализация	16.81B
EPS	$0.490 ( Q1 \| 2024-03-31 )
Дата следующего отчета о доходах	( $0 ) 2024-08-07
Last Dividend	$0.247 ( 2023-05-18 )
Next Dividend	$0 ( N/A )
P/E	37.30 (Sector) 0 (Industry) 0
ATR14	$0.0210 (0.28%)

ASSF 0.00%

BDULF 0.00%

EPWCF 0.00%

FSNUY 0.00%

GENN 0.00%

NMMCF 0.00%

PHCI 0.00%

RKAGY -7.07%

RMYHY 0.00%

RYHTY -0.79%

TPIA 0.00%

UHID -54.66%

Корреляция (AI algo v.1.1b): Undervalued: 0.81% $7.58 paired level. (Алгоритм отслеживает изменения наиболее коррелирующих акций в режиме реального времени и дает мгновенное обновление)

Объем Корреляция

Длинно: 0.16 (neutral)

Кратко: 0.52 (weak)

Signal:(55.447) Neutral

Fresenius SE & Co. KGaA Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Fresenius SE & Co. KGaA Корреляция - Валюта/Сырье

0.18
( neutral )

0.08
( neutral )

0.00
( neutral )

-0.32
( neutral )

Fresenius SE & Co. KGaA Финансовые показатели

Annual	2023
Выручка:	$22.30B
Валовая прибыль:	$5.06B (22.68 %)
EPS:	$-1.050

FY	2023
Выручка:	$22.30B
Валовая прибыль:	$5.06B (22.68 %)
EPS:	$-1.050

FY	2022
Выручка:	$40.84B
Валовая прибыль:	$10.73B (26.26 %)
EPS:	$3.77

FY	2021
Выручка:	$37.52B
Валовая прибыль:	$10.31B (27.48 %)
EPS:	$0.815

Financial Reports:

No articles found.

Fresenius SE & Co. KGaA Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0.247 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Fresenius SE & Co. KGaA Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.26 - average (75.56%) | Divividend Growth Potential Score: 1.036 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.119	2013-05-15
Last Dividend	$0.247	2023-05-18
Next Dividend	$0	N/A
Payout Date	2023-05-30
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	$2.15	--
Avg. Dividend % Per Year	0.00%	--
Score	1.7	--
Div. Sustainability Score	6.26
Div.Growth Potential Score	1.036
Div. Directional Score	3.65	--

Next Divdend (Est)
(2025-04-04)

$0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

1.70

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
18 May 2023	$0.247	13 May 2023	19 May 2023	30 May 2023
16 May 2022	$0.242	30 Nov -0001	30 Nov -0001	21 Jun 2022
24 May 2021	$0.267	19 May 2021	25 May 2021	03 Jun 2021
31 Aug 2020	$0.238	10 Jul 2020	01 Sep 2020	10 Sep 2020
20 May 2019	$0.225	08 Apr 2019	21 May 2019	30 May 2019
21 May 2018	$0.230	30 Nov -0001	22 May 2018	01 Jun 2018
15 May 2017	$0.164	29 Jun 2017	17 May 2017	24 May 2017
11 May 2016	$0.155	30 Nov -0001	13 May 2016	23 May 2016
18 May 2015	$0.123	30 Nov -0001	20 May 2015	29 May 2015
14 May 2014	$0.143	30 Nov -0001	16 May 2014	27 May 2014
15 May 2013	$0.119	30 Nov -0001	17 May 2013	28 May 2013

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
PTBS	Ex Dividend Knight	2023-08-03	Quarterly	0.00%
CHRYY	Ex Dividend Knight	2023-09-08	Annually	0.00%
LNNGY	Ex Dividend Knight	2023-08-23	Annually	0.00%
AGRPY	Ex Dividend Knight	2023-09-14	Annually	0.00%
YZCAY	Ex Dividend Junior	2023-07-03	Annually	0.00%
HARL	Ex Dividend Knight	2023-08-01	Quarterly	0.00%
SPKKY	Ex Dividend Knight	2023-09-14	Annually	0.00%
CSHX	Ex Dividend Junior	2023-07-27	Semi-Annually	0.00%
NHMD	Ex Dividend Junior	2023-08-30	Semi-Annually	0.00%
AYALY	Ex Dividend Junior	2023-07-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0243	1.500	-0.486	-0.729	[0 - 0.5]
returnOnAssetsTTM	-0.0149	1.200	-0.498	-0.598	[0 - 0.3]
returnOnEquityTTM	-0.0337	1.500	-1.486	-2.23	[0.1 - 1]
payoutRatioTTM	-1.778	-1.000	-10.00	10.00	[0 - 1]
currentRatioTTM	1.354	0.800	8.23	6.59	[1 - 3]
quickRatioTTM	0.603	0.800	-1.161	-0.929	[0.8 - 2.5]
cashRatioTTM	0.122	1.500	-0.435	-0.653	[0.2 - 2]
debtRatioTTM	0.287	-1.500	5.21	-7.82	[0 - 0.6]
interestCoverageTTM	3.11	1.000	9.96	9.96	[3 - 30]
operatingCashFlowPerShareTTM	7.60	2.00	7.47	10.00	[0 - 30]
freeCashFlowPerShareTTM	5.58	2.00	7.21	10.00	[0 - 20]
debtEquityRatioTTM	0.654	-1.500	7.38	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.231	1.000	9.48	9.48	[0.2 - 0.8]
operatingProfitMarginTTM	0.0599	1.000	-0.803	-0.803	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.337	1.000	9.24	9.24	[0.2 - 2]
assetTurnoverTTM	0.616	0.800	9.23	7.38	[0.5 - 2]
Total Score				6.26

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-5.90	1.000	-0.697	0	[1 - 100]
returnOnEquityTTM	-0.0337	2.50	-0.955	-2.23	[0.1 - 1.5]
freeCashFlowPerShareTTM	5.58	2.00	8.14	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	7.60	2.00	7.47	10.00	[0 - 30]
payoutRatioTTM	-1.778	1.500	-10.00	10.00	[0 - 1]
pegRatioTTM	-0.0128	1.500	-3.42	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.157	1.000	8.57	0	[0.1 - 0.5]
Total Score				1.036

Fresenius SE & Co. KGaA Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.